Banque Cantonale Vaudoise Exact Sciences Corp Transaction History

Banque Cantonale Vaudoise

  • $2.43 Billion
  • Q3 2024

A detailed history of Banque Cantonale Vaudoise transactions in Exact Sciences Corp stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 5,682 shares of EXAS stock, worth $280,293. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,682
Previous 12,099 53.04%
Holding current value
$280,293
Previous $512,000 24.41%
% of portfolio
0.02%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$42.43 - $70.83 $272,273 - $454,516
-6,417 Reduced 53.04%
5,682 $387,000
Q2 2024

Jul 31, 2024
BUY
$41.33 - $74.26 $217,313 - $390,459
5,258 Added 76.86%
12,099 $512,000
Q1 2024

Apr 10, 2024
BUY
$56.27 - $73.77 $101,004 - $132,417
1,795 Added 35.57%
6,841 $472,000
Q4 2023

Feb 07, 2024
SELL
$59.06 - $75.72 $313,903 - $402,451
-5,315 Reduced 51.3%
5,046 $373,000
Q3 2023

Nov 08, 2023
BUY
$65.94 - $99.04 $77,611 - $116,570
1,177 Added 12.82%
10,361 $706,000
Q2 2023

Aug 09, 2023
BUY
$62.68 - $95.05 $341,292 - $517,547
5,445 Added 145.63%
9,184 $862,000
Q1 2023

Apr 20, 2023
SELL
$47.19 - $70.77 $990 - $1,486
-21 Reduced 0.56%
3,739 $254,000
Q4 2022

Feb 10, 2023
SELL
$30.35 - $53.15 $25,554 - $44,752
-842 Reduced 18.3%
3,760 $185,000
Q3 2022

Oct 17, 2022
SELL
$31.97 - $49.37 $767 - $1,184
-24 Reduced 0.52%
4,602 $149,000
Q2 2022

Aug 02, 2022
BUY
$35.61 - $76.23 $12,071 - $25,841
339 Added 7.91%
4,626 $181,000
Q1 2022

May 09, 2022
SELL
$57.56 - $82.54 $11,512 - $16,508
-200 Reduced 4.46%
4,287 $300,000
Q4 2021

Feb 14, 2022
BUY
$72.5 - $100.68 $15,370 - $21,344
212 Added 4.96%
4,487 $350,000
Q3 2021

Oct 29, 2021
BUY
$90.24 - $124.05 $50,083 - $68,847
555 Added 14.92%
4,275 $408,000
Q2 2021

Aug 11, 2021
SELL
$93.66 - $139.27 $16,296 - $24,232
-174 Reduced 4.47%
3,720 $463,000
Q1 2021

May 11, 2021
SELL
$116.57 - $155.01 $154,921 - $206,008
-1,329 Reduced 25.45%
3,894 $513,000
Q4 2020

Feb 05, 2021
SELL
$99.61 - $142.12 $66,937 - $95,504
-672 Reduced 11.4%
5,223 $691,000
Q3 2020

Oct 30, 2020
BUY
$72.92 - $102.01 $74,888 - $104,764
1,027 Added 21.1%
5,895 $600,000
Q2 2020

Jul 22, 2020
BUY
$55.75 - $92.75 $11,596 - $19,292
208 Added 4.46%
4,868 $423,000
Q1 2020

May 14, 2020
SELL
$37.9 - $104.44 $7,163 - $19,739
-189 Reduced 3.9%
4,660 $270,000
Q4 2019

Feb 10, 2020
BUY
$77.66 - $99.74 $376,573 - $483,639
4,849 New
4,849 $448,000

Others Institutions Holding EXAS

# of Institutions
671
Shares Held
163M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.73B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email